06 Nov 2025: DDi (Drug Development informatics), a leader in regulatory, clinical, and enterprise technology solutions, has been honored with the prestigious Global 100 – 2026 Business Excellence award by GPMG. This recognition highlights DDi’s strong commitment to innovation, quality delivery, and transformative impact across the global life sciences ecosystem.
The award acknowledges DDi’s advancements in intelligent automation, data harmonization, and AI-driven platforms that simplify regulatory and clinical workflows for pharmaceutical and medical device organizations. Products like Visu, Vistaar, mIRT, smartDOC and solutions like eIFU and Regulatory Intelligence capabilities have helped life science companies improve operational efficiency, accelerate submissions, and enhance compliance transparency.
Receiving the Global 100 distinction reinforces DDi’s position as a trusted technology partner, continuously driving smarter and more connected regulatory processes worldwide.